For research use only. We do not sell to patients.
CKLF1-C27 TFA
Biological Activity：CKLF1-C27, a C-terminal peptide of CKLF1, binds to CCR4 receptor and activates ERK1/2 pathway. CKLF1-C27 can abrogate the effect of CKLF1 on cells by competing for CCR4 receptor. CKLF1-C27 shows great effect on promoting proliferation on HUVECs. CKLF1-C27 has the potential for psoriasis research.
Research Area：Inflammation/Immunology
Targets：CCR|ERK
Related Small Molecules:LMD-009;PF-04634817 succinate;Corynoxeine;Temuterkib;Vercirnon;CKLF1-C27;Bindarit;LM22B-10;ERK5-IN-4;Pachymic acid;CCR6 antagonist 1;MAP855;CCR6 inhibitor 1;CCR4-351 hydrochloride;6-OAU;BI 639667;VX-11e;Pluripotin;2,5-Dihydroxyacetophenone;Astragaloside IV;ERK1/2 inhibitor 1;Longdaysin;ML604086;CCR4 antagonist 3-1;[Tyr8] Bradykinin
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
